Literature DB >> 9685856

Characterization of a new human embryonal rhabdomyosarcoma cell line, RMS-GR.

J E Fernández1, J Prados, C Melquizo, N Arena, F Malavasi, L Alvarez, A Aránega.   

Abstract

A human tumor cell line designated RMS-GR was established from an embryonal rhabdomyosarcoma. The monolayer cells were polygonal, round or spindle-shaped. The RMS-GR cell line became stable with a doubling time of 42 h. Tumorigenicity of the cells was confirmed by heterotransplantion into nude mice. Electron microscopic images showed typical cytoplasmic inclusion of aggregated intermediate filaments and myofibril-like thin filaments. The expression of desmin, vimentin, actin and human myoglobin was recognized by cytofluorometric analyses, and a large fraction of CK-MM and small fractions of CK-BB and MCK-1 isoenzymes were found. Chromosomal analysis showed that the modal chromosome number was consistently near triploid with structural abnormalities mostly involving chromosomes 1, 3 and 8, and additional unidentified markers. No alteration of chromosome 2 was observed. The RMS-GR cell line may provide a system to identify genes which are involved in the pathogenic mechanism of rhabdomyosarcomas, and to investigate the modulation of myogenic differentiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685856      PMCID: PMC5921857          DOI: 10.1111/j.1349-7006.1998.tb03293.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


creatine kinase antibody fetal bovine serum phosphate‐buffered saline fluorescence‐activated cell sorting fluorescein isothiocyanate alkaline phosphatase anti‐alkaline phosphatase peroxidase‐antiperoxidase
  34 in total

1.  Morphological and molecular characterization of spontaneous myogenic differentiation in a human rhabdomyosarcoma cell line.

Authors:  D N Shapiro; P J Houghton; B J Hazelton; G S Germain; K G Murti; A Rahman; J A Houghton
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

2.  Chromosome 1 abnormalities: a common feature of pediatric solid tumors.

Authors:  E C Douglass; A A Green; F A Hayes; E Etcubanas; M Horowitz; J A Wilimas
Journal:  J Natl Cancer Inst       Date:  1985-07       Impact factor: 13.506

3.  Creatine kinase subunits M and B as markers in the diagnosis of poorly differentiated rhabdomyosarcomas in children.

Authors:  A S de Jong; M van Kessel-van Vark; C E Albus-Lutter; P A Voûte
Journal:  Hum Pathol       Date:  1985-09       Impact factor: 3.466

4.  12-O-tetradecanoylphorbol-13-acetate-induced differentiation of a human rhabdomyosarcoma cell line.

Authors:  S Aguanno; M Bouchè; S Adamo; M Molinaro
Journal:  Cancer Res       Date:  1990-06-01       Impact factor: 12.701

5.  In vitro differentiation and proliferation in a newly established human rhabdomyosarcoma cell line.

Authors:  A Ogose; T Motoyama; T Hotta; H Watanabe
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Nonrandom chromosome alterations in rhabdomyosarcoma.

Authors:  J Trent; J Casper; P Meltzer; F Thompson; J Fogh
Journal:  Cancer Genet Cytogenet       Date:  1985-04-01

7.  Solid alveolar rhabdomyosarcomas with the t(2;13). Report of two cases with diagnostic implications.

Authors:  D M Parham; D N Shapiro; J R Downing; B L Webber; E C Douglass
Journal:  Am J Surg Pathol       Date:  1994-05       Impact factor: 6.394

8.  Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma Study.

Authors:  W A Newton; E A Gehan; B L Webber; H B Marsden; A J van Unnik; A B Hamoudi; M G Tsokos; H Shimada; D Harms; D Schmidt
Journal:  Cancer       Date:  1995-09-15       Impact factor: 6.860

9.  Embryonal rhabdomyosarcoma with 92,XXYY, +dmin and evidence of spontaneous cell fusion.

Authors:  I Petković; M Dominis; M Nakić; M Cepulić
Journal:  Cancer Genet Cytogenet       Date:  1994-09

10.  Cytogenetic and cellular characteristics of a human embryonal rhabdomyosarcoma cell line, RMS-YM.

Authors:  K Kubo; T Naoe; K R Utsumi; Y Ishiguro; K Ueda; H Shiku; K Yamada
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

View more
  2 in total

1.  Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls.

Authors:  Ashley R P Hinson; Rosanne Jones; Lisa E S Crose; Brian C Belyea; Frederic G Barr; Corinne M Linardic
Journal:  Front Oncol       Date:  2013-07-17       Impact factor: 6.244

2.  Multidrug resistance phenotype in the RMS-GR human rhabdomyosarcoma cell line obtained after polychemotherapy.

Authors:  J Prados; C Melguizo; J A Marchal; C Vélez; L Alvarez; A Aránega
Journal:  Jpn J Cancer Res       Date:  1999-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.